Curated News
By: NewsRamp Editorial Staff
September 10, 2026
SS Innovations Brings Robotic Cardiac Surgery to Sri Lanka
TLDR
- SS Innovations launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo with its SSi Mantra 3.0 system.
- The SSi Mantra 3.0 system enabled a robotic-assisted LIMA takedown performed by Dr. Sudhir Srivastava and Dr. Rajitha DeSilva at Kings Hospital.
- This program brings advanced robotic cardiac care to Sri Lanka, potentially improving patient outcomes and access to minimally invasive surgery.
- Kings Hospital completed over 25 robotic procedures in three weeks, while SS Innovations hit 2,528 robotic procedures, up 143 percent year over year.
Impact - Why it Matters
This news matters because it demonstrates the expanding global adoption of robotic-assisted surgery, particularly in emerging markets where access to advanced medical technology has traditionally been limited. By enabling Sri Lanka’s first robotic cardiac surgery program, SS Innovations is not only improving patient outcomes but also positioning itself as a key player in the rapidly growing surgical robotics market. The company’s strong procedure growth and installation numbers indicate increasing trust in its SSi Mantra system, which could translate into significant revenue opportunities as it pursues regulatory clearances in the U.S. and Europe. For investors, this progress signals potential for further market penetration and value creation.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.
The program began with a robotic-assisted left internal mammary artery (“LIMA”) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, together with Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. The development was highlighted in a recent video from SS Innovations, which described the introduction of the program. Kings Hospital has completed more than 25 robotic procedures in three weeks, according to the video. This milestone adds to SS Innovations’ growing global footprint: the company reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company’s second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, pointing to rising utilization of the company’s installed base. The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Read More>>
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Brings Robotic Cardiac Surgery to Sri Lanka
